A randomized, open-label study of the effect of CellCept, sirolimus, and corticosteroids with or without daclizumab on the pharmacokinetics of mycophenolic acid in renal transplant patients.

Trial Profile

A randomized, open-label study of the effect of CellCept, sirolimus, and corticosteroids with or without daclizumab on the pharmacokinetics of mycophenolic acid in renal transplant patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2010

At a glance

  • Drugs Ciclosporin; Corticosteroids; Daclizumab; Mycophenolate mofetil; Sirolimus
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 26 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top